Cargando…
Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
BACKGROUND: To mitigate the cardiotoxicity of anthracycline antibiotics without compromising their anticancer activities is still an issue to be solved. We previously demonstrated that schisandrin B (Sch B) could protect against doxorubicin (Dox)-induced acute cardiotoxicity via enhancing cardiomyoc...
Autores principales: | Xu, Yang, Liu, Zhen, Sun, Jie, Pan, Qiangrong, Sun, Feifei, Yan, Zhiyu, Hu, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229562/ https://www.ncbi.nlm.nih.gov/pubmed/22164272 http://dx.doi.org/10.1371/journal.pone.0028335 |
Ejemplares similares
-
Correction: Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity
and Enhances Its Anticancer Activity In Vivo
por: Xu, Yang, et al.
Publicado: (2012) -
Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022) -
R-(-)-carvone Attenuated Doxorubicin Induced Cardiotoxicity In Vivo and Potentiated Its Anticancer Toxicity In Vitro
por: Abbas, Manal Mohammad, et al.
Publicado: (2020) -
Salvianolic Acid B Prevents Arsenic Trioxide-Induced Cardiotoxicity In Vivo and Enhances Its Anticancer Activity In Vitro
por: Wang, Min, et al.
Publicado: (2013) -
Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy
por: Li, Lan, et al.
Publicado: (2017)